⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
October 5, 2026 Deadline Approaching: Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Faruqi & Faruqi, LLP Urges ARS Pharmaceuticals (SPRY) Investors to Seek Counsel Before the October 5, 2026 Lead Plaintiff Deadline in the Securities Class Action Ready to Announce with Confidence?
newsfilecorp.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Class Action Alert: Levi & Korsinsky Reminds ARS Pharmaceuticals (SPRY) Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
SPRY
SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc. - October 5, 2026 Deadline
accessnewswire.com
SPRY
SPRY UPCOMING DEADLINE: SueWallSt Alerts ARS Pharmaceuticals Inc. Stockholders of Securities Class Action - Contact the Firm
prnewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY
prnewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Pomerantz LLP Issues Reminder to Shareholders in ARS Pharmaceuticals, Inc. of Class Action Lawsuit – SPRY
accessnewswire.com
SPRY